AgeX Therapeutics, Inc. (AGE)

Net Income Growth

-32.32%

TTM · Period ending:

AGE logo

AGE Net Income Growth

Year-over-year change vs the same period a year earlier

Latest reported-32.32%
AGE TTM Net Income YoY % (-62.01% → -32.32%)
High-resolution chart · PNG

AGE net income growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

AgeX Therapeutics, Inc. Net Income Growth — Trailing twelve months (TTM)
Period endingNet Income Growth
-32.3243%
-230.7964%
-74.4547%
-284.8384%
-38.8006%
68.9119%
34.5802%
61.4265%
7.8039%
-38.1508%
-30.6884%
-30.3805%
-27.6913%
-52.5332%
-50.2133%
-39.2949%
-16.4171%
-1.8636%
20.1565%
19.4699%
19.1142%
20.0033%
10.6056%
11.8695%
-2.1542%
-17.3846%
-62.0101%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.